SCHEMBL19240504

SCHEMBL19240504

Oc1cc(OCOc2cc(O)c(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c(O)c2)cc(O)c1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ NTSR1 P30989 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ADORA2B P29275 1/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ MAOB P27338 4/20 0.39
▸ MAOA P21397 2/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PDE5A O76074 1/20 0.38
▸ MAPT P10636 3/20 0.38
▸ HPGD P15428 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19206304 0.88 ALDH1A1 (0.49) MEN1KMT2ANTSR1ADORA3ALOX15
SCHEMBL19254052 0.84 CNR2 (0.47) L3MBTL1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL19206312 0.83 MEN1 (0.53) MEN1KMT2ANTSR1ADORA3ALOX15
SCHEMBL19240516 0.82 NPC1 (0.49) MEN1KMT2ANTSR1ADORA3TSHR
SCHEMBL19240520 0.82 FFAR1 (0.43) MEN1KMT2ANTSR1L3MBTL1ALDH1A1
SCHEMBL19240509 0.82 CNR2 (0.51) TSHRCNR1CNR2
SCHEMBL19240518 0.81 SMN1; SMN2 (0.39) MEN1KMT2ANTSR1TSHRNPC1
SCHEMBL19240519 0.81 TDP1 (0.51) MEN1KMT2ANTSR1TSHRL3MBTL1
SCHEMBL13249565 0.80 ALOX15 (0.48) MEN1KMT2ANTSR1ADORA3ALOX15
SCHEMBL19240508 0.80 CNR2 (0.46) MEN1KMT2AL3MBTL1MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170233551-A1 ULTRAVIOLET ABSORBER AND SYNTHETIC RESIN COMPOSITION ADEKA CORPORATION (JP) 2017-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170233551-A1 ULTRAVIOLET ABSORBER AND SYNTHETIC RESIN COMPOSITION RER1, XRCC5, REV1 MEN1 2103/4885KMT2A 662/4885NTSR1 824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback